These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37955105)

  • 41. Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study.
    Nayagam S; de Villiers MJ; Shimakawa Y; Lemoine M; Thursz MR; Walsh N; Hallett TB
    Lancet Gastroenterol Hepatol; 2023 Jul; 8(7):635-645. PubMed ID: 37150181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
    Minta AA; Silva MWT; Shrestha A; de Quiroz-Castro M; Tohme RA; Quimson ME; Jiz MA; Woodring J
    Vaccine; 2021 Apr; 39(14):1982-1989. PubMed ID: 33712351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
    Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019.
    Sandhu HS; Roesel S; Sharifuzzaman M; Chunsuttiwat S; Tohme RA
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(30):988-992. PubMed ID: 32730237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.
    Fischer G; Wang S; Ahring S; Fowler K; Hainline S; Chinglong M; Jacques-Carroll L; Bell B; Williams I
    Pediatr Infect Dis J; 2009 Jul; 28(7):593-7. PubMed ID: 19455073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elimination of Mother-to-Child Transmission of Hepatitis B Virus in Gulf Cooperation Council Countries: Current Status and Future Prospects.
    Al Awaidy S; Tohme RA; Al Romaihi HE; Ezzikouri S; Mahomed O
    Am J Trop Med Hyg; 2024 Jan; 110(1):32-35. PubMed ID: 38081049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization of babies born to HBsAg positive mothers: An audit on the delivery and completeness of follow up in Norfolk and Suffolk, United Kingdom.
    Keeble S; Quested J; Barker D; Varadarajan A; Shankar AG
    Hum Vaccin Immunother; 2015; 11(5):1153-6. PubMed ID: 25876072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants: A 5-year prospective study in Zhejiang Province, China (2016-2020).
    Zhou Y; Lu Z; He H; Yan R; Deng X; Tang X; Zhu Y; Xu X
    J Viral Hepat; 2021 Oct; 28(10):1413-1421. PubMed ID: 34310810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants.
    Pan CQ; Zou HB; Chen Y; Zhang X; Zhang H; Li J; Duan Z
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1349-55. PubMed ID: 23639606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).
    Tall H; Adam P; Tiendrebeogo ASE; Vincent JP; Schaeffer L; von Platen C; Fernandes-Pellerin S; Sawadogo F; Bokoum A; Bouda G; Ouattara S; Ouédraogo I; Herrant M; Boucheron P; Sawadogo A; Betsem E; Essoh A; Kabore L; Ouattara A; Méda N; Hien H; Gosset A; Giles-Vernick T; Boyer S; Kania D; Vray M; Shimakawa Y
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34206058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coverage, inequity and predictors of hepatitis B birth vaccination in Myanmar from 2011-2016: results from a national survey.
    Anderson ACT; Richards A; Delucchi K; Khalili M
    BMC Health Serv Res; 2022 Apr; 22(1):516. PubMed ID: 35436953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
    Netanel C; Ben-Aharon O; Ben-Ari Z; Chodick G; Anis E; Magnezi R
    Vaccine; 2021 Nov; 39(48):7101-7107. PubMed ID: 34782158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Epidemiological characteristics of children aged 1-4 years without timely birth dose of hepatitis B vaccine vaccination in China, 2014].
    Wang FZ; Zhang GM; Shen LP; Liu JH; Zheng H; Wang F; Miao N; Sun XJ; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):32-36. PubMed ID: 28100373
    [No Abstract]   [Full Text] [Related]  

  • 54. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: opportunities to engage the private sector.
    Patel MK; Capeding RZ; Ducusin JU; de Quiroz Castro M; Garcia LC; Hennessey K
    Vaccine; 2014 Sep; 32(39):5140-4. PubMed ID: 24361121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.
    Thompson P; Morgan CE; Ngimbi P; Mwandagalirwa K; Ravelomanana NLR; Tabala M; Fathy M; Kawende B; Muwonga J; Misingi P; Mbendi C; Luhata C; Jhaveri R; Cloherty G; Kaba D; Yotebieng M; Parr JB
    Lancet Glob Health; 2021 Nov; 9(11):e1600-e1609. PubMed ID: 34416175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B Vaccination of Low Birth Weight Infants in Washington State.
    Ost K; Oster NV; Jacobson EN; deHart MP; Englund JA; Hofstetter AM
    Am J Perinatol; 2022 Jul; 39(9):980-986. PubMed ID: 33254241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
    Yu W; Liu D; Zheng J; Liu Y; An Z; Rodewald L; Zhang G; Su Q; Li K; Xu D; Wang F; Yuan P; Xia W; Ning G; Zheng H; Chu Y; Cui J; Duan M; Hao L; Zhou Y; Wu Z; Zhang X; Cui F; Li L; Wang H
    Int J Epidemiol; 2016 Apr; 45(2):441-9. PubMed ID: 27174834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.